Dr. Muhammad Zaheer, MD

Dr. Zaheer practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Zaheer's NPI, 1356725832, was assigned on July 15, 2015. Dr. Zaheer holds Missouri license 2019038741.

Dr. Zaheer's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Zaheer's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Zaheer is also affiliated with HSHS St. Elizabeth's Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Zaheer to 1 more hospital, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaheer practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Zaheer's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Zaheer is licensed in Missouri.

CMS data shows 174 Medicare services from Dr. Zaheer across 4 procedure codes in 2024, all of them office visits, for 108 Medicare patients. Medicare paid $12,841 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Zaheer in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 73% have arthritis. 34% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zaheer's median patient age at 61, with 75% women.

In 2024, Dr. Zaheer wrote 936 Medicare Part D claims for 125 patients. 68% of them were for generic drugs. CMS names the drug for 781 of them, across 23 drugs with 11 or more claims each, at $1,581,107 in total drug cost. In 2023, CMS named 888 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Zaheer for performance year 2024, reported as part of a group. Dr. Zaheer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Zaheer, published from 2019 to 2025. 2024 was the busiest year, with 3. Dr. Zaheer has published most often in Cureus. Dr. Zaheer's most frequent co-authors are Anam Ahmad, MD, Amulya Balagani, MD and Usman A. Khan, MD.

CMS Open Payments shows 8 general payments to Dr. Zaheer from 4 drug and device companies from 2018 to 2025. Education make up the largest share, 56% of the total. Janssen Pharmaceuticals, Inc paid the most, $557.